Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Rakuten Aspyrian Raises $150M In Series C Financing
Venture Capital

Rakuten Aspyrian Raises $150M In Series C Financing

by prnewswire.com posted 9months ago 131 views
SAN DIEGO, Aug. 23, 2018 /PRNewswire/ -- Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, today announced that it has raised $150 million in a Series C financing. This round, as with previous...

In this article